Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.84K Buy
1,678
+920
+121% +$5.41K ﹤0.01% 3414
2026
Q2
$4.89K Buy
758
+110
+17% +$728 ﹤0.01% 3479
2026
Q1
$4K Buy
648
+491
+313% +$3.03K ﹤0.01% 3448
2025
Q4
$1.05K Hold
157
– – ﹤0.01% 3774
2025
Q3
$1.28K Sell
157
-342
-69% -$2.56K ﹤0.01% 3556
2025
Q2
$3.51K Sell
499
-279
-36% -$1.88K ﹤0.01% 3238
2025
Q1
$5.55K Buy
778
+683
+719% +$6.44K ﹤0.01% 3044
2024
Q4
$871 Buy
95
+21
+28% +$196 ﹤0.01% 3454
2024
Q3
$718 Buy
+74
New +$777 ﹤0.01% 3334

Other funds holding INGN

GAMMA Investing's INGN Position: Q3 2026 in Review

GAMMA Investing increased its Inogen (INGN) stake by 121% in Q3 2026, buying an estimated $5.41K and bringing the position to 1,678 shares worth $8.84K. The position accounts for ﹤0.01% of the portfolio, ranked #3414.

GAMMA Investing first reported a position in INGN in Q3 2024 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold INGN as of Q3 2026.

  • GAMMA Investing held 1,678 shares of Inogen worth $8.84K as of Q3 2026.
  • GAMMA Investing bought 920 Inogen shares in Q3 2026, an estimated $5.41K.
  • Inogen made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3414 holding.
  • GAMMA Investing first reported a position in Inogen in Q3 2024 and has held it in 9 quarters since.
  • 7 funds tracked by Wall St. Rank held Inogen as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.